Essential Partners’s AdaptHealth AHCO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$9.32K Buy
1,653
+1,213
+276% +$9.15K ﹤0.01% 1233
2026
Q2
$4.58K Sell
440
-189
-30% -$2.11K ﹤0.01% 1584
2026
Q1
$7.49K Buy
629
+334
+113% +$3.42K ﹤0.01% 1384
2025
Q4
$2.94K Buy
295
+23
+8% +$220 ﹤0.01% 1652
2025
Q3
$2.43K Buy
272
+90
+49% +$833 ﹤0.01% 1728
2025
Q2
$1.72K Buy
+182
New +$1.61K ﹤0.01% 1355

Other funds holding AHCO

Essential Partners's AHCO Position: Q3 2026 in Review

Essential Partners increased its AdaptHealth (AHCO) stake by 276% in Q3 2026, buying an estimated $9.15K and bringing the position to 1,653 shares worth $9.32K. The position accounts for ﹤0.01% of the portfolio, ranked #1233.

Essential Partners first reported a position in AHCO in Q2 2025 and has held it in 6 quarters since. 16 funds tracked by Wall St. Rank hold AHCO as of Q3 2026.

  • Essential Partners held 1,653 shares of AdaptHealth worth $9.32K as of Q3 2026.
  • Essential Partners bought 1,213 AdaptHealth shares in Q3 2026, an estimated $9.15K.
  • AdaptHealth made up ﹤0.01% of Essential Partners's portfolio in Q3 2026, its #1233 holding.
  • Essential Partners first reported a position in AdaptHealth in Q2 2025 and has held it in 6 quarters since.
  • 16 funds tracked by Wall St. Rank held AdaptHealth as of Q3 2026.

Based on Essential Partners's 13F filing for Q3 2026, filed 14 Oct 2026.